Bellberry is the largest independent reviewer of CTN trials in Australia. This year on Clinical Trials Day, we’re pleased to share a summary report which describes research activity overseen by Bellberry HRECs through 2020.
This activity report represents a significant proportion of the Australia wide CTN trial activity across the development lifecycle. It demonstrates capability and capacity in a broad range of research areas. The report also captures the originating funding location for inward investment in Sponsored clinical trials, again demonstrating Australia’s active participation in the global development process.